日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease

Hsp90在非酒精性脂肪肝疾病小鼠模型中调节PPARγ活性

Wheeler, Matthew C; Gekakis, Nicholas

Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function

肥胖突变体 PC1/3 N222D 的运输缺陷导致功能丧失

Yogikala Prabhu, Elias H Blanco, Ming Liu, Juan R Peinado, Matthew C Wheeler, Nicholas Gekakis, Peter Arvan, Iris Lindberg

A gain-of-function mutation in adenylate cyclase 3 protects mice from diet-induced obesity

腺苷酸环化酶3的功能获得性突变可保护小鼠免受饮食诱导的肥胖症的影响

Pitman, Jeffrey L; Wheeler, Matthew C; Lloyd, David J; Walker, John R; Glynne, Richard J; Gekakis, Nicholas

Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites

Mia2(一种定位于内质网出口位点的肝脏蛋白)发生突变的小鼠体内胆固醇和甘油三酯降低

Jeffrey L Pitman, David J Bonnet, Linda K Curtiss, Nicholas Gekakis

A point mutation in Sec61alpha1 leads to diabetes and hepatosteatosis in mice

Sec61alpha1的点突变导致小鼠患上糖尿病和肝脂肪变性

David J Lloyd, Matthew C Wheeler, Nicholas Gekakis

Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance

肌生长抑制素功能丧失突变可减少肿瘤坏死因子 α 的产生并保护肝脏免受肥胖引起的胰岛素抵抗

Jason J Wilkes, David J Lloyd, Nick Gekakis

Negative regulators of insulin signaling revealed in a genome-wide functional screen

全基因组功能筛选揭示胰岛素信号的负调节剂

Shih-Min A Huang, Michael K Hancock, Jeffrey L Pitman, Anthony P Orth, Nicholas Gekakis

A role for Alström syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence

Alström综合征蛋白alms1在肾脏纤毛发生和细胞静止中的作用

Li, Guochun; Vega, Raquel; Nelms, Keats; Gekakis, Nicholas; Goodnow, Christopher; McNamara, Peter; Wu, Hua; Hong, Nancy A; Glynne, Richard

Diabetes insipidus in mice with a mutation in aquaporin-2

水通道蛋白2基因突变小鼠的尿崩症

Lloyd, David J; Hall, Frank Wesley; Tarantino, Lisa M; Gekakis, Nicholas